Otsuka Pharma gets USFDA approval for Brexpiprazole to treat Alzheimer’s agitation Reuters May 12, 2023 Brexpiprazole was previously approved in the US to treat adults with major depressive disorder and schizophrenia
FDA approves new drug Rexulti to treat schizophrenia Usha Sharma Jul 14, 2015 Rexulti was shown to reduce the occurrence of symptoms of schizophrenia compared to placebo (inactive tablet)
